Nippon Chemiphar Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3701600003
JPY
1,568.00
2 (0.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
RaQualia Pharma, Inc.
Koa Shoji Holdings Co., Ltd.
Fuji Pharma Co., Ltd.
Noile-Immune Biotech, Inc.
Nippon Chemiphar Co., Ltd.
Fuso Pharmaceutical Industries Ltd.
Healios KK
Taiko Pharmaceutical Co., Ltd.
SymBio Pharmaceuticals Ltd.
CanBas Co., Ltd.
BrightPath Biotherapeutics Co., Ltd.

Why is Nippon Chemiphar Co., Ltd. ?

1
Poor Management Efficiency with a low ROCE of 1.68%
  • The company has been able to generate a Return on Capital Employed (avg) of 1.68% signifying low profitability per unit of total capital (equity and debt)
2
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.89
  • Poor long term growth as Net Sales has grown by an annual rate of 0.90% and Operating profit at 18.19% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.89
  • The company has been able to generate a Return on Equity (avg) of 2.50% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 0.90% and Operating profit at 18.19% over the last 5 years
4
The company has declared Negative results for the last 3 consecutive quarters
  • INTEREST(9M) At JPY 173 MM has Grown at 11.61%
  • PRE-TAX PROFIT(Q) At JPY 17 MM has Fallen at -88.91%
  • NET PROFIT(Q) At JPY 75 MM has Fallen at -52.46%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nippon Chemiphar Co., Ltd. for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Nippon Chemiphar Co., Ltd.
6.38%
0.01
22.36%
Japan Nikkei 225
85.83%
3.09
27.80%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
0.90%
EBIT Growth (5y)
18.19%
EBIT to Interest (avg)
1.89
Debt to EBITDA (avg)
4.02
Net Debt to Equity (avg)
0.52
Sales to Capital Employed (avg)
0.88
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
61.36%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.68%
ROE (avg)
2.50%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.39
EV to EBIT
37.37
EV to EBITDA
8.75
EV to Capital Employed
0.59
EV to Sales
0.53
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
1.59%
ROE (Latest)
3.28%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NET SALES(Q)

Highest at JPY 8,833 MM

-20What is not working for the Company
INTEREST(9M)

At JPY 173 MM has Grown at 11.61%

PRE-TAX PROFIT(Q)

At JPY 17 MM has Fallen at -88.91%

NET PROFIT(Q)

At JPY 75 MM has Fallen at -52.46%

RAW MATERIAL COST(Y)

Grown by 11.89% (YoY

CASH AND EQV(HY)

Lowest at JPY 12,347 MM

DEBT-EQUITY RATIO (HY)

Highest at 57.62 %

EPS(Q)

Lowest at JPY -24.28

Here's what is working for Nippon Chemiphar Co., Ltd.

Net Sales
Highest at JPY 8,833 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Depreciation
Highest at JPY 419 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Nippon Chemiphar Co., Ltd.

Pre-Tax Profit
At JPY 17 MM has Fallen at -88.91%
over average net sales of the previous four periods of JPY 153.25 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (JPY MM)

Interest
At JPY 173 MM has Grown at 11.61%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Profit
At JPY 75 MM has Fallen at -52.46%
over average net sales of the previous four periods of JPY 157.75 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (JPY MM)

EPS
Lowest at JPY -24.28
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (JPY)

Cash and Eqv
Lowest at JPY 12,347 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio
Highest at 57.62 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 11.89% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales